Press Releases

Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance

Posted on

EDEN PRAIRIE, Minn., August 16, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today the appointment of Megan Brandt to the position of Vice President of Regulatory Affairs and Quality Assurance. In this capacity, Ms. Brandt will facilitate and manage quality and regulatory affairs for Sunshine Heart. “Megan brings to the company a specific […]

Read More

Sunshine Heart Announces Second Quarter 2016 Financial Results and Provides Company Update

Posted on

EDEN PRAIRIE, Minn., Aug. 09, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the second quarter ended June 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on the Company’s clinical and product […]

Read More

Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank

Posted on

EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients […]

Read More

Sunshine Heart Announces $3.5 Million Offering

Posted on

EDEN PRAIRIE, Minn., July 21, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (Nasdaq:SSH) (“Sunshine Heart” or the “Company”), today announced that it has entered into a definitive agreement with a single investor for an offering of shares of convertible preferred stock with gross proceeds of $3,468,000 in a registered direct offering. The closing of the […]

Read More

Sunshine Heart Announces Clinical Update and Product Development Strategy

Posted on

EDEN PRAIRIE, Minn., July 11, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions. After months of collecting data and researching an optimal strategic path forward, Sunshine Heart is moving forward […]

Read More